Mannose-binding lectin (MBL) levels in children with Hashimoto's thyroiditis

Area of Science:

• Immunology
• Endocrinology
• Pediatrics

Background:

• Hashimoto's thyroiditis (HT) is an autoimmune condition with unclear origins.
• Mannose-binding lectin (MBL) plays a role in the immune system by initiating complement activation.
• Understanding factors influencing HT pathogenesis is crucial for effective management.

Purpose of the Study:

• To investigate serum Mannose-binding lectin (MBL) levels in pediatric patients diagnosed with Hashimoto's thyroiditis (HT).
• To explore the association between MBL levels and thyroid hormone status (euthyroid, hypothyroidism, hyperthyroidism) in children with HT.
• To determine any correlation between MBL levels and thyroid autoantibodies (anti-TPO, anti-TG) in this cohort.

Main Methods:

• A cohort of 39 children with HT and 41 healthy controls were recruited.
• Serum MBL levels were quantified using an MBL Human ELISA kit.
• Statistical analyses compared MBL levels across thyroid function groups and correlated them with clinical parameters.

Main Results:

• Serum MBL levels were comparable between children with HT and control subjects (50.79±34.72 vs. 50.59±44.28 ng/ml, p=0.983).
• No significant differences in MBL levels were observed among euthyroid, hypothyroid, or hyperthyroid HT subgroups (p=0.869).
• A negative correlation was found between white blood cell count (WBC) and serum MBL levels (r=-0.532, p=0.050); no correlations with TSH, anti-TPO, or anti-TG were detected.

Conclusions:

• Serum Mannose-binding lectin (MBL) levels do not appear to be reduced in children with Hashimoto's thyroiditis.
• The study did not find a direct association between MBL levels and thyroid hormone status or autoantibodies in pediatric HT.
• Further investigation is warranted to fully elucidate the potential role of MBL in the pathogenesis of autoimmune thyroid disease.